News
A Major Advance in Pancreatic Cancer Care
A new drug called daraxonrasib nearly doubled survival rates for patients... Here goes the content ...
University of Miami researchers report that biomarkers and MRI show similar performance in predicting prostate cancer risk. Combining blood biomarkers with cognitive testing improves prediction of functional decline in people at risk for Alzheimer’s disease. Researchers at the Diabetes Research Institute are using engineering-based models to investigate how lymph node environments may drive type 1 diabetes. The $10 million donation will enable Dr. Field F. Willingham to advance the growth of a division focused on innovation.
Five Radiation Treatments Match 26 for Localized Prostate Cancer, Miami HEAT Trial Finds
Blood Biomarkers and Cognitive Testing Improve Prediction of Early Alzheimer’s Decline
Engineering New Clues to Type 1 Diabetes at the Diabetes Research Institute
Gift from Citadel Founder and CEO Kenneth C. Griffin Brings Eminent Gastroenterologist to Miller School and UHealth as Division Chief
